AGM Presentation
Melbourne, Nov 25, 2016 AEST (ABN Newswire) - Bluechiip Ltd (
ASX:BCT) is pleased to provide the company's AGM Presentation.
Bluechiip
Sample tracking for extreme environments using MEMS sensors
The Company
- Founded in 2003
- Listed on Australian Securities Exchange (ASX) in 2011
- Head office in Melbourne, Australia
- Global Distribution Network
- Key manufacturing partners in Europe, UK and Malaysia.
- OEM Partnering agreement in Assisted Reproductive Technologies (ART) and IVF
- OEM Partnering agreement with Planet Innovation (BRW's Most Innovative Company '14,'15,'16)
- Strong IP portfolio - 24 granted patents, 7 pending in 10 patent families
Our Product : Chip + Reader + Software
- Unique technology, superior to labels, barcodes and RFID
- Operates reliably down to -196 DEG C
- Instant sample temperature sensing
- Gamma resistant
- Reduces human error
- Increases productivity
- Extremely difficult to copy
- Applications in niche markets, e.g. cryogenic storage and biobanking
2016 Pipeline and Results
- Partner pipeline grown to over 30 opportunities
- Genea Biomedx - OEM Supply Agreement Executed
- Planet Innovation - OEM Supply Agreement and Investment
- 9 Developer & Starter Kit Sales Accelerating
-- Mar: Autism CRC - End user. Ongoing consumables
-- Jun: US Cryogenics consumables manufacturer
--- Australian researcher organisation
-- Aug: Centre for Disease Control China (CDC China)
-- Sep: US Auto ID and Data Capture Company
-- Nov: Kit sale to CDC China
--- 2 Kit sales to SIAD in EU - biobank solution provider
--- Kit sale to Denmark University - OEM validator
Summary
1. Well protected and expanding differentiated IP portfolio
2. Large growing target market with very large adjacent market opportunities
3. Dramatically increasing partner pipeline with well advanced product development
4. Partner opportunity conversion with 2 executed licence and supply agreements
5. Initial repeat revenues with licence, service and product sales expected to grow in FY'17 on partner's product launch
To view the presentation, please visit:
http://abnnewswire.net/lnk/JN980482
About Bluechiip Limited
Bluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.
Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.
Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.
Bluechiip: Delivering confidence in every sample.
| ||
|
